Functional regulation of interleukin-31 production by its genetic polymorphism in patients with extrinsic atopic dermatitis.

[1]  T. Werfel,et al.  Functional effects of interleukin 31 in human primary keratinocytes , 2011, Allergy.

[2]  C. Lam,et al.  Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis. , 2010, International immunology.

[3]  S. Chevalier,et al.  Molecular Dissection of Human Interleukin-31-mediated Signal Transduction through Site-directed Mutagenesis* , 2009, The Journal of Biological Chemistry.

[4]  S. Ständer,et al.  Correlation of IL-31 serum levels with severity of atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.

[5]  U. Wahn,et al.  A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. , 2007, The Journal of allergy and clinical immunology.

[6]  K. Kelsay.  Management of sleep disturbance associated with atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.

[7]  M. Steinhoff,et al.  IL-31: a new link between T cells and pruritus in atopic skin inflammation. , 2006, The Journal of allergy and clinical immunology.

[8]  B. Harder,et al.  IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.

[9]  S. Nakaike,et al.  Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. , 2005, European journal of pharmacology.

[10]  Scott R. Presnell,et al.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice , 2004, Nature Immunology.